FASEB JOURNAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182590, encodeId=5f35218259035, content=偏重的研究方向：心血管 经验分享：请问大家，提交之后显示状态Quality control check underway，之后收到关于sciscorc的邮件，状态还是Quality control check underway，是什么情况？需要改什么内容吗？之后需要怎么做？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:48:35 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2173795, encodeId=f1e721e37953e, content=偏重的研究方向：肿瘤生物学 经验分享：请问用自己账号投稿后，提交的最后一步是必须要发给通讯作者吗？我看有这个的按钮，但没说必须, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Fri Dec 08 22:35:57 CST 2023, time=2023-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147178, encodeId=0877214e178aa, content=投稿后没有让缴审稿费，所有作者都没有收到邮件，目前状态是Under consideration，这正常么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jul 09 21:56:02 CST 2023, time=2023-07-09, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155239, encodeId=ce702155239aa, content=偏重的研究方向：心血管方向动物细胞实验 经验分享：投稿2天后收到接收到的邮件，现在是第7天，一直都是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMHq0lDK5YPwjSkVrChzNHAuicLJsibYVjqkA8pdGPY1N5Y0T88vnrDdqViasVyEH3qBibEy0ibbiczPeA/132, createdBy=a5952055308, createdName=朝曦, createdTime=Wed Aug 30 07:55:06 CST 2023, time=2023-08-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2130651, encodeId=08482130651a0, content=一般接收之后几天可以见刊呀！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Sun May 07 00:29:53 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107737, encodeId=f1d0210e737a6, content=有没有前辈帮我解答一下这是什么情况，状态栏是这样子的，到现在快一个月了，没变化 Under consideration 2022-12-02 09:03 Out for review 2022-11-27 20:28 Under consideration 2022-11-27 20:28 Out for review 2022-11-27 13:43 Under consideration 2022-11-11 00:44 Preliminary Submission Data Submitted 2022-11-10 22:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Dec 27 21:03:57 CST 2022, time=2022-12-27, status=1, ipAttribution=湖南省)]

2024-01-19 ms6000001226293924 来自河北省

偏重的研究方向：心血管
经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182590, encodeId=5f35218259035, content=偏重的研究方向：心血管 经验分享：请问大家，提交之后显示状态Quality control check underway，之后收到关于sciscorc的邮件，状态还是Quality control check underway，是什么情况？需要改什么内容吗？之后需要怎么做？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:48:35 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2173795, encodeId=f1e721e37953e, content=偏重的研究方向：肿瘤生物学 经验分享：请问用自己账号投稿后，提交的最后一步是必须要发给通讯作者吗？我看有这个的按钮，但没说必须, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Fri Dec 08 22:35:57 CST 2023, time=2023-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147178, encodeId=0877214e178aa, content=投稿后没有让缴审稿费，所有作者都没有收到邮件，目前状态是Under consideration，这正常么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jul 09 21:56:02 CST 2023, time=2023-07-09, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155239, encodeId=ce702155239aa, content=偏重的研究方向：心血管方向动物细胞实验 经验分享：投稿2天后收到接收到的邮件，现在是第7天，一直都是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMHq0lDK5YPwjSkVrChzNHAuicLJsibYVjqkA8pdGPY1N5Y0T88vnrDdqViasVyEH3qBibEy0ibbiczPeA/132, createdBy=a5952055308, createdName=朝曦, createdTime=Wed Aug 30 07:55:06 CST 2023, time=2023-08-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2130651, encodeId=08482130651a0, content=一般接收之后几天可以见刊呀！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Sun May 07 00:29:53 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107737, encodeId=f1d0210e737a6, content=有没有前辈帮我解答一下这是什么情况，状态栏是这样子的，到现在快一个月了，没变化 Under consideration 2022-12-02 09:03 Out for review 2022-11-27 20:28 Under consideration 2022-11-27 20:28 Out for review 2022-11-27 13:43 Under consideration 2022-11-11 00:44 Preliminary Submission Data Submitted 2022-11-10 22:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Dec 27 21:03:57 CST 2022, time=2022-12-27, status=1, ipAttribution=湖南省)]

2024-01-19 tears1115 来自河北省

偏重的研究方向：心血管
经验分享：请问大家，提交之后显示状态Quality control check underway，之后收到关于sciscorc的邮件，状态还是Quality control check underway，是什么情况？需要改什么内容吗？之后需要怎么做？

19 0

[GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182590, encodeId=5f35218259035, content=偏重的研究方向：心血管 经验分享：请问大家，提交之后显示状态Quality control check underway，之后收到关于sciscorc的邮件，状态还是Quality control check underway，是什么情况？需要改什么内容吗？之后需要怎么做？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:48:35 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2173795, encodeId=f1e721e37953e, content=偏重的研究方向：肿瘤生物学 经验分享：请问用自己账号投稿后，提交的最后一步是必须要发给通讯作者吗？我看有这个的按钮，但没说必须, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Fri Dec 08 22:35:57 CST 2023, time=2023-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147178, encodeId=0877214e178aa, content=投稿后没有让缴审稿费，所有作者都没有收到邮件，目前状态是Under consideration，这正常么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jul 09 21:56:02 CST 2023, time=2023-07-09, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155239, encodeId=ce702155239aa, content=偏重的研究方向：心血管方向动物细胞实验 经验分享：投稿2天后收到接收到的邮件，现在是第7天，一直都是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMHq0lDK5YPwjSkVrChzNHAuicLJsibYVjqkA8pdGPY1N5Y0T88vnrDdqViasVyEH3qBibEy0ibbiczPeA/132, createdBy=a5952055308, createdName=朝曦, createdTime=Wed Aug 30 07:55:06 CST 2023, time=2023-08-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2130651, encodeId=08482130651a0, content=一般接收之后几天可以见刊呀！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Sun May 07 00:29:53 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107737, encodeId=f1d0210e737a6, content=有没有前辈帮我解答一下这是什么情况，状态栏是这样子的，到现在快一个月了，没变化 Under consideration 2022-12-02 09:03 Out for review 2022-11-27 20:28 Under consideration 2022-11-27 20:28 Out for review 2022-11-27 13:43 Under consideration 2022-11-11 00:44 Preliminary Submission Data Submitted 2022-11-10 22:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Dec 27 21:03:57 CST 2022, time=2022-12-27, status=1, ipAttribution=湖南省)]

2023-12-08 ms9000001758785175 来自上海

偏重的研究方向：肿瘤生物学
经验分享：请问用自己账号投稿后，提交的最后一步是必须要发给通讯作者吗？我看有这个的按钮，但没说必须

46 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182590, encodeId=5f35218259035, content=偏重的研究方向：心血管 经验分享：请问大家，提交之后显示状态Quality control check underway，之后收到关于sciscorc的邮件，状态还是Quality control check underway，是什么情况？需要改什么内容吗？之后需要怎么做？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:48:35 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2173795, encodeId=f1e721e37953e, content=偏重的研究方向：肿瘤生物学 经验分享：请问用自己账号投稿后，提交的最后一步是必须要发给通讯作者吗？我看有这个的按钮，但没说必须, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Fri Dec 08 22:35:57 CST 2023, time=2023-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147178, encodeId=0877214e178aa, content=投稿后没有让缴审稿费，所有作者都没有收到邮件，目前状态是Under consideration，这正常么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jul 09 21:56:02 CST 2023, time=2023-07-09, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155239, encodeId=ce702155239aa, content=偏重的研究方向：心血管方向动物细胞实验 经验分享：投稿2天后收到接收到的邮件，现在是第7天，一直都是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMHq0lDK5YPwjSkVrChzNHAuicLJsibYVjqkA8pdGPY1N5Y0T88vnrDdqViasVyEH3qBibEy0ibbiczPeA/132, createdBy=a5952055308, createdName=朝曦, createdTime=Wed Aug 30 07:55:06 CST 2023, time=2023-08-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2130651, encodeId=08482130651a0, content=一般接收之后几天可以见刊呀！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Sun May 07 00:29:53 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107737, encodeId=f1d0210e737a6, content=有没有前辈帮我解答一下这是什么情况，状态栏是这样子的，到现在快一个月了，没变化 Under consideration 2022-12-02 09:03 Out for review 2022-11-27 20:28 Under consideration 2022-11-27 20:28 Out for review 2022-11-27 13:43 Under consideration 2022-11-11 00:44 Preliminary Submission Data Submitted 2022-11-10 22:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Dec 27 21:03:57 CST 2022, time=2022-12-27, status=1, ipAttribution=湖南省)]

2023-06-16 tjutiger 来自山东省

审稿速度:6.0 | 投稿命中率:50.0
经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？

41 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182590, encodeId=5f35218259035, content=偏重的研究方向：心血管 经验分享：请问大家，提交之后显示状态Quality control check underway，之后收到关于sciscorc的邮件，状态还是Quality control check underway，是什么情况？需要改什么内容吗？之后需要怎么做？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:48:35 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2173795, encodeId=f1e721e37953e, content=偏重的研究方向：肿瘤生物学 经验分享：请问用自己账号投稿后，提交的最后一步是必须要发给通讯作者吗？我看有这个的按钮，但没说必须, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Fri Dec 08 22:35:57 CST 2023, time=2023-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147178, encodeId=0877214e178aa, content=投稿后没有让缴审稿费，所有作者都没有收到邮件，目前状态是Under consideration，这正常么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jul 09 21:56:02 CST 2023, time=2023-07-09, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155239, encodeId=ce702155239aa, content=偏重的研究方向：心血管方向动物细胞实验 经验分享：投稿2天后收到接收到的邮件，现在是第7天，一直都是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMHq0lDK5YPwjSkVrChzNHAuicLJsibYVjqkA8pdGPY1N5Y0T88vnrDdqViasVyEH3qBibEy0ibbiczPeA/132, createdBy=a5952055308, createdName=朝曦, createdTime=Wed Aug 30 07:55:06 CST 2023, time=2023-08-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2130651, encodeId=08482130651a0, content=一般接收之后几天可以见刊呀！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Sun May 07 00:29:53 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107737, encodeId=f1d0210e737a6, content=有没有前辈帮我解答一下这是什么情况，状态栏是这样子的，到现在快一个月了，没变化 Under consideration 2022-12-02 09:03 Out for review 2022-11-27 20:28 Under consideration 2022-11-27 20:28 Out for review 2022-11-27 13:43 Under consideration 2022-11-11 00:44 Preliminary Submission Data Submitted 2022-11-10 22:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Dec 27 21:03:57 CST 2022, time=2022-12-27, status=1, ipAttribution=湖南省)]

2023-07-09 1591f99c2fm 来自河南省

投稿后没有让缴审稿费，所有作者都没有收到邮件，目前状态是Under consideration，这正常么？

27 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182590, encodeId=5f35218259035, content=偏重的研究方向：心血管 经验分享：请问大家，提交之后显示状态Quality control check underway，之后收到关于sciscorc的邮件，状态还是Quality control check underway，是什么情况？需要改什么内容吗？之后需要怎么做？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:48:35 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2173795, encodeId=f1e721e37953e, content=偏重的研究方向：肿瘤生物学 经验分享：请问用自己账号投稿后，提交的最后一步是必须要发给通讯作者吗？我看有这个的按钮，但没说必须, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Fri Dec 08 22:35:57 CST 2023, time=2023-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147178, encodeId=0877214e178aa, content=投稿后没有让缴审稿费，所有作者都没有收到邮件，目前状态是Under consideration，这正常么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jul 09 21:56:02 CST 2023, time=2023-07-09, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155239, encodeId=ce702155239aa, content=偏重的研究方向：心血管方向动物细胞实验 经验分享：投稿2天后收到接收到的邮件，现在是第7天，一直都是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMHq0lDK5YPwjSkVrChzNHAuicLJsibYVjqkA8pdGPY1N5Y0T88vnrDdqViasVyEH3qBibEy0ibbiczPeA/132, createdBy=a5952055308, createdName=朝曦, createdTime=Wed Aug 30 07:55:06 CST 2023, time=2023-08-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2130651, encodeId=08482130651a0, content=一般接收之后几天可以见刊呀！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Sun May 07 00:29:53 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107737, encodeId=f1d0210e737a6, content=有没有前辈帮我解答一下这是什么情况，状态栏是这样子的，到现在快一个月了，没变化 Under consideration 2022-12-02 09:03 Out for review 2022-11-27 20:28 Under consideration 2022-11-27 20:28 Out for review 2022-11-27 13:43 Under consideration 2022-11-11 00:44 Preliminary Submission Data Submitted 2022-11-10 22:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Dec 27 21:03:57 CST 2022, time=2022-12-27, status=1, ipAttribution=湖南省)]

2023-06-21 ms5000001632088774 来自湖南省

审稿速度:2.0
偏重的研究方向：生物分子学
经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。

43 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182590, encodeId=5f35218259035, content=偏重的研究方向：心血管 经验分享：请问大家，提交之后显示状态Quality control check underway，之后收到关于sciscorc的邮件，状态还是Quality control check underway，是什么情况？需要改什么内容吗？之后需要怎么做？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:48:35 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2173795, encodeId=f1e721e37953e, content=偏重的研究方向：肿瘤生物学 经验分享：请问用自己账号投稿后，提交的最后一步是必须要发给通讯作者吗？我看有这个的按钮，但没说必须, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Fri Dec 08 22:35:57 CST 2023, time=2023-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147178, encodeId=0877214e178aa, content=投稿后没有让缴审稿费，所有作者都没有收到邮件，目前状态是Under consideration，这正常么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jul 09 21:56:02 CST 2023, time=2023-07-09, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155239, encodeId=ce702155239aa, content=偏重的研究方向：心血管方向动物细胞实验 经验分享：投稿2天后收到接收到的邮件，现在是第7天，一直都是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMHq0lDK5YPwjSkVrChzNHAuicLJsibYVjqkA8pdGPY1N5Y0T88vnrDdqViasVyEH3qBibEy0ibbiczPeA/132, createdBy=a5952055308, createdName=朝曦, createdTime=Wed Aug 30 07:55:06 CST 2023, time=2023-08-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2130651, encodeId=08482130651a0, content=一般接收之后几天可以见刊呀！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Sun May 07 00:29:53 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107737, encodeId=f1d0210e737a6, content=有没有前辈帮我解答一下这是什么情况，状态栏是这样子的，到现在快一个月了，没变化 Under consideration 2022-12-02 09:03 Out for review 2022-11-27 20:28 Under consideration 2022-11-27 20:28 Out for review 2022-11-27 13:43 Under consideration 2022-11-11 00:44 Preliminary Submission Data Submitted 2022-11-10 22:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Dec 27 21:03:57 CST 2022, time=2022-12-27, status=1, ipAttribution=湖南省)]

2023-08-30 朝曦来自北京

偏重的研究方向：心血管方向动物细胞实验
经验分享：投稿2天后收到接收到的邮件，现在是第7天，一直都是under consideration

32 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182590, encodeId=5f35218259035, content=偏重的研究方向：心血管 经验分享：请问大家，提交之后显示状态Quality control check underway，之后收到关于sciscorc的邮件，状态还是Quality control check underway，是什么情况？需要改什么内容吗？之后需要怎么做？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:48:35 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2173795, encodeId=f1e721e37953e, content=偏重的研究方向：肿瘤生物学 经验分享：请问用自己账号投稿后，提交的最后一步是必须要发给通讯作者吗？我看有这个的按钮，但没说必须, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Fri Dec 08 22:35:57 CST 2023, time=2023-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147178, encodeId=0877214e178aa, content=投稿后没有让缴审稿费，所有作者都没有收到邮件，目前状态是Under consideration，这正常么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jul 09 21:56:02 CST 2023, time=2023-07-09, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155239, encodeId=ce702155239aa, content=偏重的研究方向：心血管方向动物细胞实验 经验分享：投稿2天后收到接收到的邮件，现在是第7天，一直都是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMHq0lDK5YPwjSkVrChzNHAuicLJsibYVjqkA8pdGPY1N5Y0T88vnrDdqViasVyEH3qBibEy0ibbiczPeA/132, createdBy=a5952055308, createdName=朝曦, createdTime=Wed Aug 30 07:55:06 CST 2023, time=2023-08-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2130651, encodeId=08482130651a0, content=一般接收之后几天可以见刊呀！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Sun May 07 00:29:53 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107737, encodeId=f1d0210e737a6, content=有没有前辈帮我解答一下这是什么情况，状态栏是这样子的，到现在快一个月了，没变化 Under consideration 2022-12-02 09:03 Out for review 2022-11-27 20:28 Under consideration 2022-11-27 20:28 Out for review 2022-11-27 13:43 Under consideration 2022-11-11 00:44 Preliminary Submission Data Submitted 2022-11-10 22:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Dec 27 21:03:57 CST 2022, time=2022-12-27, status=1, ipAttribution=湖南省)]

2023-05-07 ms7000000175049819 来自湖南省

一般接收之后几天可以见刊呀！！！！

46 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182590, encodeId=5f35218259035, content=偏重的研究方向：心血管 经验分享：请问大家，提交之后显示状态Quality control check underway，之后收到关于sciscorc的邮件，状态还是Quality control check underway，是什么情况？需要改什么内容吗？之后需要怎么做？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:48:35 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2173795, encodeId=f1e721e37953e, content=偏重的研究方向：肿瘤生物学 经验分享：请问用自己账号投稿后，提交的最后一步是必须要发给通讯作者吗？我看有这个的按钮，但没说必须, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Fri Dec 08 22:35:57 CST 2023, time=2023-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147178, encodeId=0877214e178aa, content=投稿后没有让缴审稿费，所有作者都没有收到邮件，目前状态是Under consideration，这正常么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jul 09 21:56:02 CST 2023, time=2023-07-09, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155239, encodeId=ce702155239aa, content=偏重的研究方向：心血管方向动物细胞实验 经验分享：投稿2天后收到接收到的邮件，现在是第7天，一直都是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMHq0lDK5YPwjSkVrChzNHAuicLJsibYVjqkA8pdGPY1N5Y0T88vnrDdqViasVyEH3qBibEy0ibbiczPeA/132, createdBy=a5952055308, createdName=朝曦, createdTime=Wed Aug 30 07:55:06 CST 2023, time=2023-08-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2130651, encodeId=08482130651a0, content=一般接收之后几天可以见刊呀！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Sun May 07 00:29:53 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107737, encodeId=f1d0210e737a6, content=有没有前辈帮我解答一下这是什么情况，状态栏是这样子的，到现在快一个月了，没变化 Under consideration 2022-12-02 09:03 Out for review 2022-11-27 20:28 Under consideration 2022-11-27 20:28 Out for review 2022-11-27 13:43 Under consideration 2022-11-11 00:44 Preliminary Submission Data Submitted 2022-11-10 22:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Dec 27 21:03:57 CST 2022, time=2022-12-27, status=1, ipAttribution=湖南省)]

2023-03-23 ms8000000700114189 来自广东省

偏重的研究方向：生物学
经验分享：二审过了7天了，还是没有消息，害

50 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2182595, encodeId=43fb21825951d, content=偏重的研究方向：心血管 经验分享：请问大家，投稿之后现实状态quality control cjeck underway,之后收到关于sciscore的邮件，状态依旧不变，请问大家需要怎么做？修改什么内容还是等着？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ad9150605, createdName=ms6000001226293924, createdTime=Fri Jan 19 10:57:01 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182590, encodeId=5f35218259035, content=偏重的研究方向：心血管 经验分享：请问大家，提交之后显示状态Quality control check underway，之后收到关于sciscorc的邮件，状态还是Quality control check underway，是什么情况？需要改什么内容吗？之后需要怎么做？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKSyDa955A78iaibFibwvmVSFQghIicGVa0HmOuKV8WPMAgrgSNia0H1hCUJx3g8icLOehE6Yscciawr60pg/132, createdBy=bf855079934, createdName=tears1115, createdTime=Fri Jan 19 10:48:35 CST 2024, time=2024-01-19, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2173795, encodeId=f1e721e37953e, content=偏重的研究方向：肿瘤生物学 经验分享：请问用自己账号投稿后，提交的最后一步是必须要发给通讯作者吗？我看有这个的按钮，但没说必须, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47d98750326, createdName=ms9000001758785175, createdTime=Fri Dec 08 22:35:57 CST 2023, time=2023-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2143105, encodeId=202a2143105af, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志即便选择订阅模式，不OA，也要交2800美金版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f27764445, createdName=tjutiger, createdTime=Fri Jun 16 11:06:34 CST 2023, time=2023-06-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2147178, encodeId=0877214e178aa, content=投稿后没有让缴审稿费，所有作者都没有收到邮件，目前状态是Under consideration，这正常么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f912115742, createdName=1591f99c2fm, createdTime=Sun Jul 09 21:56:02 CST 2023, time=2023-07-09, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144084, encodeId=918b214408459, content=审稿速度:2.0 偏重的研究方向：生物分子学 经验分享：第一次外审回来了14天了，编辑部都没给我返回评审意见。一直卡在编辑部。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff685697071, createdName=ms5000001632088774, createdTime=Wed Jun 21 12:25:44 CST 2023, time=2023-06-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155239, encodeId=ce702155239aa, content=偏重的研究方向：心血管方向动物细胞实验 经验分享：投稿2天后收到接收到的邮件，现在是第7天，一直都是under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIMHq0lDK5YPwjSkVrChzNHAuicLJsibYVjqkA8pdGPY1N5Y0T88vnrDdqViasVyEH3qBibEy0ibbiczPeA/132, createdBy=a5952055308, createdName=朝曦, createdTime=Wed Aug 30 07:55:06 CST 2023, time=2023-08-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2130651, encodeId=08482130651a0, content=一般接收之后几天可以见刊呀！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Sun May 07 00:29:53 CST 2023, time=2023-05-07, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121367, encodeId=1be6212136ea6, content=偏重的研究方向：生物学 经验分享：二审过了7天了，还是没有消息，害, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac658288936, createdName=ms8000000700114189, createdTime=Thu Mar 23 16:30:08 CST 2023, time=2023-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107737, encodeId=f1d0210e737a6, content=有没有前辈帮我解答一下这是什么情况，状态栏是这样子的，到现在快一个月了，没变化 Under consideration 2022-12-02 09:03 Out for review 2022-11-27 20:28 Under consideration 2022-11-27 20:28 Out for review 2022-11-27 13:43 Under consideration 2022-11-11 00:44 Preliminary Submission Data Submitted 2022-11-10 22:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477b6494743, createdName=ms7000000175049819, createdTime=Tue Dec 27 21:03:57 CST 2022, time=2022-12-27, status=1, ipAttribution=湖南省)]

2022-12-27 ms7000000175049819 来自湖南省

有没有前辈帮我解答一下这是什么情况，状态栏是这样子的，到现在快一个月了，没变化
Under consideration 2022-12-02 09:03
Out for review 2022-11-27 20:28
Under consideration 2022-11-27 20:28
Out for review 2022-11-27 13:43
Under consideration 2022-11-11 00:44
Preliminary Submission Data Submitted 2022-11-10 22:10

48 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务